Consolidated Statements of Operations and Comprehensive Income - CAD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2017 |
Dec. 31, 2016 |
| Profit or loss [abstract] |
|
|
| Product sales |
$ 4,082
|
$ 554
|
| Cost of sales |
|
|
| Inventory expensed to cost of sales |
4,489
|
384
|
| Production costs |
3,983
|
356
|
| Unrealized gain on revaluation of biological assets |
(11,620)
|
(2,179)
|
| Total recovery of cost of sales |
(3,148)
|
(1,439)
|
| Gross profit |
7,230
|
1,993
|
| Operating expenses |
|
|
| General and administration |
6,935
|
3,435
|
| Stock-based payments |
1,862
|
307
|
| Depreciation |
541
|
382
|
| Total operating expenses |
9,338
|
4,124
|
| Operating loss |
(2,108)
|
(2,131)
|
| Other income (expense) |
|
|
| Interest expense |
(126)
|
(232)
|
| Share of income from Whistler investment |
165
|
163
|
| Gain (loss) on other investments |
4,858
|
(310)
|
| Reversal of impairment loss on loan receivable |
|
725
|
| Other income |
|
27
|
| Total other income |
4,897
|
373
|
| Income (loss) before income taxes |
2,789
|
(1,758)
|
| Income tax expense (recovery) |
298
|
(568)
|
| Net income (loss) |
2,491
|
(1,190)
|
| Other comprehensive income |
|
|
| Gain on revaluation of other investments, net of tax |
947
|
1,584
|
| Unrealized gains reclassified to net income |
(1,651)
|
|
| Comprehensive income |
$ 1,787
|
$ 394
|
| Net income (loss) per share |
|
|
| Basic |
$ 0.02
|
$ (0.02)
|
| Diluted |
$ 0.01
|
$ (0.02)
|
| Weighted average number of outstanding shares |
|
|
| Basic |
134,803,542
|
78,248,192
|
| Diluted |
176,789,161
|
78,248,192
|